Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01XX69
|
| gptkbp:chemicalFormula |
C41H44N4O10S
|
| gptkbp:developedBy |
gptkb:PharmaMar
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lurbinectedin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
binds to DNA minor groove
inhibits transcription |
| gptkbp:otherName |
gptkb:Zepzelca
PM01183 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
vomiting constipation fatigue decreased appetite myelosuppression |
| gptkbp:usedFor |
treatment of small cell lung cancer
|
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|